FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

BERLIN (Reuters) – The supervisory board of Bayer is planning an extraordinary meeting to discuss a crisis of confidence in its leadership after an investor rebuke at the German drugmaker’s annual meeting, a magazine reported on Wednesday.

Citing an unnamed board member, Wirtschaftswoche magazine said the meeting would take place in the next two or three weeks: “We can’t just carry on like this,” the person said.

A Bayer spokesman declined to comment.

At Bayer’s annual shareholder meeting on Friday a majority of investors cast a vote of disapproval of top management’s actions.

On Saturday, the supervisory board said